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Abstract Dactylitis is a common feature of psoriatic arthritis
(PsA); local physical trauma has been identified as a possible
contributing factor. The aim of this study was to explore dif-
ferences in forefoot plantar pressures in patients with PsAwith
and without dactylitis and compare to healthy controls. Thirty-
six participants were recruited into three groups: group A PsA
plus a history of dactylitis; group B PsA, no dactylitis; group
C control participants. Forefoot plantar pressures were mea-
sured barefoot and in-shoe at the left second and fourth toes
and corresponding metatarsophalangeal joints. Temporal and
spatial parameters were measured and data from the foot im-
pact scale for rheumatoid arthritis (FIS-RA), EQ5D and health
assessment questionnaire (HAQ) were collected. Pressure
time integral peak plantar pressure, and contact time barefoot
and in-shoe were not significantly different between groups.
Temporal and spatial parameters reported no significant dif-
ferences between groups. ANOVA analysis and subsequent
post hoc testing using Games-Howell test yielded significance
in FIS-RA scores between both PsA groups versus controls, A
p≤0.0001 and PsA group B p<0.0001 in the FIS-RA impair-
ment and footwear domain, PsA group A p<0.03 and PsA
group B p≤ 0.05 in the FIS-RA activity and participation
domain compared to controls. This is the first exploratory
study to investigate forefoot plantar pressures in patients with
and without historical dactylitis in PsA. FIS-RA scores indi-
cate PsA patients have significant limitations compared to
controls, although a history of dactylitis does not appear to
worsen patient reported outcomes.
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Introduction
Levels of peripheral joint damage are lower in psoriatic arthri-
tis (PsA) compared to rheumatoid arthritis (RA), although foot
impairment and disability are reported in two thirds of patients
particularly at the forefoot [1]. Patients report a reduction in
quality of life, with limitations in function and disability de-
scribed as equivalent to that of RA. Despite lower levels of
peripheral joint damage however the effect on patients report-
ed pain and disability are significant [2, 3]. Dactylitis is one of
the most common features of PsA occurring in around 40% of
cases. It is classed as a hallmark feature of the disease and
forms part of the classification criteria for PsA [4].
Dactylitis, also referred to as sausage digit presents clinically
as an acute painful inflammation of the digit which in the
chronic phase can remain swollen following the subsidence
of acute inflammation.
Magnetic resonance imaging (MRI) studies have identified
dactylitis as a polyarticular disease process, with multiple pa-
thologies and varying levels of severity. Bone oedema and
flexor tenosynovitis have been observed and, to a lesser de-
gree, extensor tenosynovitis. Furthermore, synovitis and soft
tissue oedema occur in tender and non-tender dactylitis [5].
Trauma has been suggested as a potential trigger for PsA and
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direct physical injury may influence peripheral manifestations
such as dactylitis and enthesitis. Furthermore, high levels of
stress at entheses are suggested as a biomechanical trigger to
enthesitis and the other manifestations of the disease [6].
It has been hypothesised that dactylitis in the hand may be
caused by mechanical trauma to distal phalangeal and meta-
carpal joints. This is thought to result in an inflammatory
response at the digit, known as the ‘deep Koebner’
phenomenon [4, 7, 8]. Toe dactylitis is more common than
finger dactylitis which may support the mechanical pathogen-
esis hypothesis given the load bearing function of the toes, but
there are no investigations to support a mechanical trigger [7,
8]. It has also been suggested that psoriatic nail disease may be
linked to micro trauma occurring within the nail bed [9].
Pain at the forefoot has been reported in RA to reduce the
ambulatory performance in the presence of foot deformity and
pain. Localised foot painmay lead to altered changes in temporal
and spatial parameters of gait leading to altered gait patterns and
functional adaption [10, 11]. During normal walking, the toes
function to increase the total weight-bearing area of the forefoot
and disperse themechanical load from themetatarsal-phalangeal
(MTP) joints [12]. At the propulsive phase of gait where forefoot
forces are highest, muscle activation occurs to facilitate propul-
sion.Forcegeneratedat the forefootandmusculature is increased,
which in inflammatory diseases such as PsA maybe abnormal
leading tochanges inplantarpressures [12,13].Although the role
ofplantarMTPjointpressuredistributionshavebeeninvestigated
in PsA, no study has investigated toe dactylitis [14]. In other
systemic conditions, such as RA and diabetes, increases in
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Fig. 1 Distribution of current (chronic) and historical dactylitis in both feet
Table 1 Demographics, disease
variables and patient reported
outcome measures
Group
PsA dactylitis
(group A)
PsA no history of dactylitis
(group B)
Normal
(group C)
Demographics (SD) (range)
Gender M:F 11:1 4:8 7:5
Age, mean 36.7 (21.5) (25–58) 45.3 (16.2) (20–81) 39.7 (8.8) (29–58)
Disease duration (y) 4.6 (6.7) (1–25) 4.6 (5.6) (1–20) 0 (0)
Weight (kg) 90.9 (21.5) (54–133) 81.3 (29.8) (51–162) 71.8 (15) (48–98)
Height (m) 1.8 (0.1) (1.6–1.9) 1.7 (0.1) (1.5–1.9) 1.7 (0.1) (1.8–1.9)
Medication (n)
DMARDs 10 11 0
Biologics 7 6 0
FIS-RA (SD) (range)
FIS-RA (SD) (range)
FIS-RAIF 7.16 (5.78) (0–15) 6.83 (4.19) (0–12) 0.41 (0.79) (0–2)
95 % CI lower bound 3.49 4.16 −0.08
95 % CI upper bound 10.84 9.49 0.92
FIS-RAAP 8.75 (10.22) (0–25) 5.75 (7.30) (0–22) 0.16 (0.38) (0–1)
95 % CI lower bound 2.25 1.11 −0.08
95 % CI upper bound 15.24 10.38 0.41
EQ-5D
Mobility 1.42 (0.51) 1.50 (0.52) 1.0 (0)
Self-care 1.25 (0.45) 1.08 (0.28) 1.0 (0)
Activity 1.50 (0.67) 1.50 (0.52) 1.08 (0.28)
Pain 1.67 (0.49) 1.67 (0.49) 1.17 (0.38)
Anxiety 1.25 (0.45) 1.33 (0.49) 1.00 (0)
VAS 66.67 (23.17) 78.33 (14.63) 89.78 (9.9)
HAQ 0.45 (0.84) 0.30 (0.41) 0.03 (0.10)
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pressure and the time over which pressure occurs have been
linked to mechanical tissue damage and ulceration [10, 15, 16].
To the authors’knowledge, no studyhas investigated the effect of
toe dactylitis.
It is therefore the aim of this exploratory study to investi-
gate variations in plantar pressures at the most commonly
reported sites of dactylitis and their corresponding MTP joints
in patients with a history of dactylitis when compared to con-
trols (PsA, no history of dactylitis) and normal participants.
Method
Ethical approval was obtained from the NRES Committee
Yorkshire and Humber—Leeds East. Written informed con-
sent was obtained from all participants.
The study was cross-sectional in design with 36 participants
recruited as a convenience sample of consecutive patients iden-
tified by two consultant rheumatologists. Twelve participants
with PsA and a previous history of dactylitis/chronic dactylitis
(group A) and 12 participants with PsA but no previous history
of dactylitis (group B) were recruited from the rheumatology
outpatient department, Chapel Allerton Hospital, Leeds
Teaching Hospitals NHS Trust. A control group of 12 heathy
participants were also recruited (group C). These control partic-
ipants did not report any musculoskeletal or rheumatological
disease and had no current or medical history of foot and ankle
pain. Control participants were age (+/− 2 years) and gender
matched. Disease duration (years) was recorded for all patients
with PsA. The sites of historical dactylitis (digit number, left/
right) were recorded for all PsA patients in group A.
The EQ-5D was used to capture participant health status
and self-rated health. The health assessment questionnaire
(HAQ) was also used and provided a measure of the patient’s
health, functional status, symptoms, and quality of life from
the participants’ own perspective. Both EQ-5D and HAQ
have been reported in PsA previously (ref). The foot impact
scale for rheumatoid arthritis (FIS-RA) was used to measure
the impact of foot pathology on impairment and footwear
(FIS-RAIF), and activity limitation and participation restric-
tion (FIS-RAAP) [17]. Although the FIS-RA is not specific
to PsA it has been used previously [2].
Temporal and spatial parameters of walking were collected
using the GAITRite system, a 10-metre instrumented walkway.
Barefoot plantar pressure measurement and dynamic foot/shoe
interface pressures were collected using the novel eMED SF
and Pedar in-shoe systems (Novel GmbH, Munich, Germany),
respectively.Peakplantarpressure (PPP) (kPa), contactarea (CA)
(cm2)andpressure timeintegral (PTI) (kPa/s)wereanalysedat the
mostcommon(fourth toe)andsecondmostcommon(secondtoe)
sites of dactylitis and correspondingmetatarsophalangeal (MTP)
joints.Three representative stepswerecollected forbarefootpres-
sures using a common two-step start protocol [18, 19]. Dynamic
in-shoe pressure was collected by inserting a flexible pressure
measuring insole into the participant’s footwear. The participant
undertook two straight linewalks of an 8-mwalkway generating
20 representative steps [19].
Data analysis
A sample size of 36 was used (12 participants per group),
based on a rationale including feasibility, precision about the
Table 2 Post hoc test Games-Howell FIS-RA subscales
Groups
PsA dactylitis
(group A)
(1)
PsA no history of dactylitis
(group B)
(1)
Normal
(group C)
(1)
PsA no history of dactylitis
(group B)
(2)
Normal
(group C)
(2)
PsA dactylitis
(group A)
(2)
Normal
(group C)
(2)
PsA dactylitis
(group A)
(2)
PsA no history of dactylitis
(group B)
(2)
FIS-RAIF
Mean difference (1and 2) 0.33 6.75 −0.33 1.23 1.68 1.23
Sig. 0.986 0.00 0.986 0.00 0.00 0.00
95 % CI lower bound −4.88 2.28 −5.54 3.11 −11.27 −9.71
95 % CI upper bound 5.54 11.27 4.88 9.71 −2.22 −3.11
FIS-RAAP
Mean difference (1 and 2) 3.00 8.58 −3.00 5.58 −8.58 −5.58
Sig. 0.691 0.03 0.69 0.05 0.03 0.05
95 % CI lower bound −6.179 0.60 −12.17 −0.11 −16.55 −11.27
95 % CI upper bound 12.17 16.55 6.17 11.27 −0.60 0.11
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mean and variance and regulatory considerations for sample
size calculations [20]. The most symptomatic foot (left) in
group A (PsA dactylitis) was selected for analysis (Fig. 1).
IBM Statistical package for Social Sciences (SPSS) Version
19 for Windows 7 was used to analyse data. Descriptive sta-
tistics were used to report patient demographics, between-
group spatial and temporal parameters (gait velocity (m/s),
cadence (steps/min) and period of double support (%)).
Between-group differences were explored using a one-way
analysis of variance (ANOVA) for PPP (kPa), PTI (kPa/s)
and the FIS-RA. A subsequent Games-Howell post hoc test
explored differences between paired combinations of the three
groups (A and B, B and C, C and A). A p value of ≤0.05 was
chosen to detect the probability.
Results
Thirty-six participants were analysed for this exploratory
study. Patient demographics, patient-reported outcome mea-
sures and temporal and spatial data are presented descriptively
in Table 1.
Descriptive of HAQ and EQ-5D are reported in Table 1.
There were no significant differences between groups. In the
FIS-RA amean FIS-RAIF score of 7.16 in group A and 6.83 in
group B compared to 0.41 in the control group, and a mean
FIS-RAAP score of 8.75 in group A and 5.75 in group B
compared to 0.16 in the control group; ANOVA analysis and
subsequent post-hoc testing identified statistically significance
differences between groups in FIS-RA scores (Table 2). In
both domains of the FIS-RA, there was a significant difference
between both PsA groups compared to the control group; PsA
group A p=0.0001 and PsA group B p=0.0001 in the FIS-
RAIF domain, PsA group A p=0.03 and PsA group B p=0.05
in the FIS-RAAP domain.
Descriptive statistics of mean plantar pressure variables
(PPP, PTI, CA) are reported in Table 3. ANOVA analysis of
measurements barefoot and in-shoe (Table 4) indicated no
significant differences between groups. No significant differ-
ences were reported in spatial and temporal parameters of gait
between groups (Table 1).
Discussion
This is the first study to explore the mechanical factors that
may contribute to toe dactylitis in patients with PsA and to
examine the impact of dactylitis on foot pain and disability.
Table 3 Gait and plantar pressure descriptive statistics
Temporal and spatial (SD) (range)
Velocity (m/s) 1.23 (0.17) (0.59–1.44) 1.23 (0.24) (0.59–1.44) 1.47 (0.14) (1.28–1.75)
Cadence 116.8 (7.34) (103–125) 120.03 (9.26) (105–138) 120.26 (5.57) (110–128)
Double support (% of gait cycle left) 22.56 (3.17) (17–28) 23.67 (4.40) (19–33) 19.55 (2.31) (15–22)
Double support (% of gait cycle right) 22.61 (3.19) (18–28) 23.40 (4.42) (20–33) 19.27 (2.36) (15–22)
PP/PTI/CA Emed-SF (SD) (range)
PP left 2nd toe 296.6 (238) (62–952) 197.3 (97.3) (0–317) 245.6 (128.8) (68–455)
PP left 4th toe 88.2 (55.8) (15–232) 81.4 (90.2) (0–292) 122.7 (82.9) (10–272)
PP left 2nd MTP joint 555.3 (260.3) (110–1035) 601.8 (242.8) (268–1047) 633.6 (305.5) (353–1235)
PP left 4th MTP joint 372.8 (203.8) (75–753) 330.4 (128.7) (208–698) 314.5 (104) (170–492)
PTI left 2nd toe 64.3 (54.2) (18–211) 38.9 (21.1) (0–64) 51.2 (37.8) (13–158)
PTI left 4th toe 19.5 (13.2) (1–50) 19.3 (24.9) (0–83) 28.5 (20.8) (1–64)
PTI left 2nd MTP joint 162.4 (64.4) (17–259) 188 (88.3) (66–330) 167.3 (62.3) (92–288)
PTI left 4th MTP joint 135.3 (74.9) (24–267) 110.4 (38.7) (76–212) 100.8 (33.9) (58–181)
Contact area left 2nd toe 3.78 (.50) (0–2) 3.39 (1.34) 3.70 (.93)
Contact area left 4th toe 2.52 (.88) 1.96 (1.52) 2.68 (.92)
Contact area left 2nd MTP joint 9.82 (1.43) 9.90 (1.81) 9.70 (1.14)
Contact area left 4th MTP joint 9.11 (1.86) 8.89 (1.49) 8.87 (1.30)
PP/ PTI/CA PEDAR (SD) (range)
PP left lesser toes 117.9 (45.1) (54–194) 110 (42.2) (24–162) 108.7 (43.6) (64–228)
PP Left MTP joints 301.9 (68.2) (165–454) 271.4 (100.8) (164–482) 300.7 (71.8) (215–455)
PTI left lesser toes 301.9 (68.2) (165–454) 271.4 (100.8) (164–482) 300.7 (71.8) (215–455)
PTI left MTP joints 84.12 (35.2) (54–167) 74.5 (30.9) (37–128) 68.32 (14.6) (45–96)
CA left lesser toes 8.1 (1.1) (3.7) 6.6 (2.5) (10.3) 7.4 (0.9) (2.9)
CA left MTP joints 18.4 (2.9) (11.5) 15.5 (5.3) (21.3) 17.4 (3.3) (10.6)
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Patients with PsA, with and without dactylitis, reported worse
impairment, footwear, activity limitation and participant re-
striction when compared to a control group of normal partic-
ipants. Analysis of peak plantar pressure, pressure time inte-
gral and contact area at the 2nd and 4th toes, and 2nd and 4th
MTP joints of the left foot found no significant differences
between groups. Descriptive analysis of temporal and spatial
parameters of gait identified no differences between any of the
three groups (A, B, C). Having a history of dactylitis did not
have a significant effect on plantar pressure measurement and
patient-reported foot impact in patients with PsA.
This study in PsA has provided an insight in to the
mechanical factors that may be associated with toe
dactylitis and aided the formation of a hypothesis for a
future study. Although differences in PsA PPP, PTI and
contact area were not identified, the results indicate that
pressure may not be as relevant to the cause of trauma as
previously hypothesised. In other diseases, such as RA,
inflammatory changes at the forefoot leads to altered
joint mechanics and increased plantar pressures [10].
This was not the finding of this study and supports the
research carried out by Turner et al. who reported plantar
pressures at the MTP joint did not correlate to joint dam-
age and pain in patients with PsA [14]. Active or histor-
ical dactylitis did not correlate with changes in plantar
pressures. Investigating the effect of dorsal and plantar
shear force on the forefoot structures in the future may
provide more insight into mechanical properties of soft
tissue.
Limitations
The authors acknowledge several limitations to this study.
Whilst a sample size of 12 per group is accepted in an
exploratory study the inability to adequately power may
increase the risk of error. A power calculation using the
new data indicates that 60 participants per group would be
needed to demonstrate a significant difference between
groups if these results were found. Capturing details of
disease activity may have provided more insight into the
condition and the patient disease status at the point of data
collection such as active systemic inflammation which
may affect the patient’s ability to weight bear through
the forefoot. Including both chronic and historical
dactylitis may have affected results. The inclusion of his-
torical dactylitis in group A may have negatively impact-
ed on the results and lessened the impact that current
dactylitis may have had on gait parameter and altered
function. Details of foot deformity, foot posture and foot-
wear characteristics may also provide insight into plantar
pressure data reported and contributing factors such as
foot type, poor fitting footwear or poor mechanical
properties.
Conclusion
In conclusion, the main finding of this exploratory study is
that patient-reported functional limitation and disability in
PsA is significant, regardless of whether or not there is a
history of dactylitis. Further research is necessary in larger
patient numbers using more sophisticated measures, and cap-
turing variables of foot type, foot deformity and footwear in
conjunction with disease activity scores to determine whether
Table 4 ANOVA one-way analysis of emed-SF barefoot and PEDAR
in-shoe data contact area (CA), peak plantar pressures (PPP) and pressure
time integral (PTI)
Mean square Sig.
PPP left 2nd toe Between groups 5035.533 0.43
Within groups 5961.038
PPP left 4th toe Between groups 15499.007 0.48
Within groups 21111.535
PPP left 2nd MTP joint Between groups 17317.560 0.78
Within groups 69591.536
PPP left 4th MTP joint Between groups 37784.462 0.27
Within groups 27993.069
PTI left 2nd toe Between groups 37784.462 0.27
Within groups 27993.069
PTI left 4th toe Between groups 37784.462 0.27
Within groups 27993.069
PTI left 2nd MTP joint Between groups 37784.462 0.27
Within groups 27993.069
PTI left 4th MTP joint Between groups 37784.462 0.27
Within groups 27993.069
CA left 2nd toe Between groups 0.936 0.40
Within groups 0.986
CA left 4th toe Between groups 1.719 0.28
Within groups 1.315
CA left 2nd MTP joint Between groups 0.123 0.85
Within groups 2.228
CA left 4th MTP joint Between groups 0.225 0.91
Within groups 2.475
PEDAR PPP left toes Between groups 291.323 0.85
Within groups 1908.989
PEDAR PPP left MTP joints Between groups 3369.648 0.60
Within groups 6543.641
PEDAR PTI left toes Between groups 23.181 0.81
Within groups 112.885
PEDAR PTI left MTP joints Between groups 759.532 0.39
Within groups 797.616
PEDAR CA left MTP toes Between groups 6.483 0.11
Within groups 2.697
PEDAR CA left MTP joints Between groups 24.984 0.22
Within groups 15.485
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variations in plantar pressures contribute to the manifestation
of dactylitis in the toes of patients with PsA.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Hyslop E, Turner DE, McInnes IB, Woodburn J (2008) An outpa-
tient survey of foot problems in psoriatic arthritis (PSA). Paper
presented at the EULAR, Paris
2. Hyslop E, McInnes IB, Woodburn J, Turner DE (2010) Foot prob-
lems in psoriatic arthritis: high burden and low care provision. Ann
Rheum Dis 69(5):928. doi:10.1136/ard.2009.111971
3. Boehncke W-H, Menter A (2013) Burden of disease: psoriasis and
psoriatic arthritis. Am J Clin Dermatol 14(5):377–388
4. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P,
Mielants H (2006) Classification criteria for psoriatic arthritis: de-
velopment of new criteria from a large international study. Arthritis
Rheum 54(8):2665–2673
5. Healy PJ, Groves C, Chandramohan M, Helliwell PS (2008) MRI
changes in psoriatic dactylitis—extent of pathology, relationship to
tenderness and correlation with clinical indices. Rheumatology
(Oxford) 47(1):92–95
6. McGonagle D, Tan AL, Benjamin M (2008) The biomechanical link
between skin and joint disease in psoriasis and psoriatic arthritis: what
every dermatologist needs to know. Ann Rheum Dis 67(1):1–4
7. CHANDRAN V (2009) Epidemiology of psoriatic arthritis. J
Rheumatol 36(2):213–215
8. Coates LC (2010) Improving the outcome of psoriatic arthritis.
University of Leeds, Unpublished. http://etheses.whiterose.ac.uk/1425
9. Rich P, Griffiths CE, Reich K, Nestle FO, Scher RK, Li S et al
(2008) Baseline nail disease in patients with moderate to severe
psoriasis and response to treatment with infliximab during 1 year.
J Am Acad Dermatol 58(2):224–231
10. Van der Leeden M, Steultjens M, Dekker J, Prins A, Dekker J (2006)
Forefoot joint damage, pain and disability in rheumatoid arthritis pa-
tients with foot complaints: the role of plantar pressure and gait charac-
teristics. Rheumatology 45(4):465–469
11. Hyslop E, Woodburn J, McInnes IB, Semple R, Newcombe L,
Hendry G et al (2010) A reliability study of biomechanical foot
function in psoriatic arthritis based on a novel multi-segmented foot
model. Gait Posture 32(4):619–626. doi:10.1016/j.gaitpost.2010.
09.004
12. Jacob H (2001) Forces acting in the forefoot during normal gait—
an estimate. Clin Biomech 16(9):783–792
13. Chao CY, Zheng Y-P, Huang Y-P, Cheing GL (2010)
Biomechanical properties of the forefoot plantar soft tissue as mea-
sured by an optical coherence tomography-based air-jet indentation
system and tissue ultrasound palpation system. Clin Biomech
25(6):594–600
14. Turner DE, Hyslop E, Barn R, McInnes IB, Steultjens MP,
Woodburn J (2013) Metatarsophalangeal joint pain in psoriatic ar-
thritis: a cross-sectional study. Rheumatology ket435
15. Woodburn J, Helliwell P (1996) Relation between heel position and
the distribution of forefoot plantar pressures and skin callosities in
rheumatoid arthritis. Ann Rheum Dis 55(11):806–810
16. Pai S, Ledoux WR (2012) The shear mechanical properties
of diabetic and non-diabetic plantar soft tissue. J Biomech
45(2):364–370
17. Helliwell P, Reay N, Gilworth G, Redmond A, Slade A, Tennant A,
Woodburn J (2005) Development of a foot impact scale for rheu-
matoid arthritis. Arthritis Care Res 53(3):418–422
18. Quaney B, Meyer K, Cornwall MW, McPoil TG (1995) A compar-
ison of the dynamic pedobarograph and EMED systems for mea-
suring dynamic foot pressures. Foot Ankle Int 16(9):562–566
19. Alcacer-Pitarch B, Buch MH, Gray J, Denton CP, Herrick A,
Navarro-Coy N et al (2012) Pressure and pain in systemic sclero-
sis/scleroderma—an evaluation of a simple intervention (PISCES):
randomised controlled trial protocol. BMC Musculoskelet Disord
13(1):11
20. Julious SA (2005) Sample size of 12 per group rule of thumb for a
pilot study. Pharm Stat 4(4):287–291
2338 Clin Rheumatol (2016) 35:2333–2338
